Related Experiment Video
Updated: Aug 9, 2026
An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
In combination, nucleoside reverse transcriptase inhibitors have significant effects on 3T3-L1 adipocyte lipid
Lisa A Kosmiski1, Heidi L Miller, Dwight J Klemm
1Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, University of Colorado Health Sciences Center, Denver, CO, USA. lisa.kosmiski@uchsc.edu
Abstract:
The use of nucleoside reverse transcriptase inhibitors (NRTIs) for the treatment of HIV infection is clearly linked to the development of subcutaneous fat atrophy. Until recently, however, in vitro studies of adipocytes have shown no or only modest and inconsistent effects of these agents on adipocyte biology. This is in contrast to the protease inhibitors (PIs), which are also linked to the development of HIV lipodystrophy. These agents have relatively consistent inhibitory effects on the differentiation of cultured adipocytes, and have occasionally been found to have other effects on adipocyte biology as well. We aimed to explore more thoroughly the effects of NRTIs and combinations of antiretroviral agents commonly used in clinical practice on multiple aspects of adipocyte biology using the 3T3-L1 adipocyte cell line. We found that when used individually, NRTIs decrease cell survival but only lamivudine significantly alters lipid accumulation. However, NRTI and dual NRTI-PI combinations do significantly decrease lipid accumulation in 3T3-L1 adipocytes, have a much greater detrimental impact on cell survival and decrease adipocyte differentiation.
Insights
Nucleoside reverse transcriptase inhibitors (NRTIs) used for HIV treatment can harm fat cells. Combinations of NRTIs and protease inhibitors (PIs) significantly reduce fat accumulation and cell survival in lab studies.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Nucleoside reverse transcriptase inhibitors (NRTIs) are linked to subcutaneous fat atrophy in HIV patients.
- Previous in vitro studies showed limited effects of NRTIs on adipocyte biology, contrasting with protease inhibitors (PIs).
- HIV lipodystrophy involves fat redistribution, with PIs showing consistent inhibitory effects on adipocyte differentiation.
Purpose of the Study:
- To investigate the effects of NRTIs and common antiretroviral combinations on adipocyte biology.
- To utilize the 3T3-L1 adipocyte cell line for comprehensive analysis.
- To compare the impact of individual NRTIs versus NRTI-PI combinations on adipocytes.
Main Methods:
- Culturing 3T3-L1 adipocytes.
- Treating adipocytes with individual NRTIs, dual NRTI-PI combinations.
- Assessing cell survival, lipid accumulation, and adipocyte differentiation.
Main Results:
- Individual NRTIs decreased cell survival; only lamivudine significantly altered lipid accumulation.
- NRTI and dual NRTI-PI combinations significantly decreased lipid accumulation in 3T3-L1 adipocytes.
- These combinations had a greater detrimental impact on cell survival and reduced adipocyte differentiation.
Conclusions:
- NRTIs and their combinations with PIs negatively affect adipocyte biology, including survival and differentiation.
- Findings provide in vitro evidence for the mechanisms behind NRTI-associated lipodystrophy.
- Further research is needed to understand the clinical implications of these cellular effects.
Related Concept Videos
01:22Antiviral Nucleoside Inhibitors
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones